Jim Simons Xencor Inc Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Xencor Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 43,600 shares of XNCR stock, worth $825,348. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,600

Previous 180,300 75.82%

Holding current value

$825,348

Previous $3.83 Million 74.79%

% of portfolio

0.0%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$18.65 - $26.52 $2.55 Million - $3.63 Million	-136,700 Reduced 75.82%	43,600 $965,000
Q4 2023 Feb 13, 2024	BUY	$16.53 - $21.42 $2.25 Million - $2.91 Million	136,000 Added 307.0%	180,300 $3.83 Million
Q3 2023 Nov 14, 2023	SELL	$20.08 - $25.39 $1.69 Million - $2.13 Million	-83,973 Reduced 65.46%	44,300 $893,000
Q2 2023 Aug 11, 2023	BUY	$24.77 - $29.9 $403,082 - $486,562	16,273 Added 14.53%	128,273 $3.2 Million
Q1 2023 May 12, 2023	BUY	$25.95 - $36.95 $225,765 - $321,465	8,700 Added 8.42%	112,000 $3.12 Million

Q4 2022 Feb 13, 2023	SELL	$24.79 - $30.86 $265,253 - $330,202	-10,700 Reduced 9.39%	103,300 $2.69 Million
Q3 2022 Nov 14, 2022	SELL	$24.62 - $32.44 $856,776 - $1.13 Million	-34,800 Reduced 23.39%	114,000 $2.96 Million
Q2 2022 Aug 12, 2022	SELL	$19.74 - $29.01 $1.7 Million - $2.5 Million	-86,100 Reduced 36.65%	148,800 $4.07 Million
Q1 2022 May 13, 2022	BUY	$26.68 - $41.63 $6.27 Million - $9.78 Million	234,900 New	234,900 $6.27 Million
Q4 2021 Feb 11, 2022	SELL	$33.67 - $43.44 $1.96 Million - $2.53 Million	-58,200 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$30.65 - $35.68 $2.48 Million - $2.89 Million	-80,900 Reduced 58.16%	58,200 $1.9 Million
Q2 2021 Aug 13, 2021	BUY	$34.33 - $44.68 $2.29 Million - $2.98 Million	66,800 Added 92.39%	139,100 $4.8 Million
Q1 2021 May 13, 2021	BUY	$40.81 - $53.88 $2.62 Million - $3.46 Million	64,256 Added 798.81%	72,300 $3.11 Million
Q4 2020 Feb 10, 2021	BUY	$36.63 - $47.63 $294,651 - $383,135	8,044 New	8,044 $351,000
Q3 2019 Nov 13, 2019	SELL	$33.73 - $46.27 $1.03 Million - $1.41 Million	-30,500 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$29.6 - $40.93 $503,200 - $695,810	17,000 Added 125.93%	30,500 $1.25 Million
Q1 2019 May 14, 2019	BUY	$27.85 - $38.09 $375,975 - $514,215	13,500 New	13,500 $419,000

Others Institutions Holding XNCR

# of Institutions

203

Shares Held

64M

Call Options Held

2.2K

Put Options Held

1.3K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.13B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account